ATYR
aTyr Pharma
ATYR
ATYR
80 hedge funds and large institutions have $55.7M invested in aTyr Pharma in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
22% less funds holding
Funds holding: 103 → 80 (-23)
60% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 35
Holders
80
Holding in Top 10
1
Calls
$770K
Puts
$499K
Top Buyers
| 1 | +$1.58M | |
| 2 | +$690K | |
| 3 | +$632K | |
| 4 |
Morgan Stanley
New York
|
+$568K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$524K |
Top Sellers
| 1 | -$2.36M | |
| 2 | -$2.03M | |
| 3 | -$1.36M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$549K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$484K |
